Posted by
- HUTCHMED (NASDAQ:HCM) entered into two agreements to divest its 45% equity interest in Shanghai Hutchison Pharmaceuticals (SHPL) for approximately $608 million in cash, to GP Health Service Capital and Shanghai Pharmaceuticals.
- HUTCHMED has been exploring opportunities to monetize the underlying